See more : Zwack Unicum Nyrt. (ZWACK.BD) Income Statement Analysis – Financial Results
Complete financial analysis of Quipt Home Medical Corp. (QIPT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Quipt Home Medical Corp., a leading company in the Medical – Devices industry within the Healthcare sector.
You may be interested
- FinCanna Capital Corp. (FNNZF) Income Statement Analysis – Financial Results
- Mountain & Co. I Acquisition Corp. (MCAA) Income Statement Analysis – Financial Results
- John Wiley & Sons, Inc. (JW-B) Income Statement Analysis – Financial Results
- Prosperous Future Holdings Limited (1259.HK) Income Statement Analysis – Financial Results
- Wolverine Energy and Infrastructure Inc. (WEIIF) Income Statement Analysis – Financial Results
Quipt Home Medical Corp. (QIPT)
About Quipt Home Medical Corp.
Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. In addition, it provides nebulizers, oxygen concentrators, CPAP and BiPAP units, ventilator equipment and aids, daily and ambulatory aides, equipment solutions, power wheelchairs, oxygen therapy, bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, compressors, patient lifts, walkers, products for wound care, and medical equipment for home-based sleep apnea and chronic obstructive pulmonary disease treatments, as well as rents respiratory equipment. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 245.92M | 221.74M | 139.86M | 102.35M | 54.85M | 61.16M | 59.49M | 61.56M | 105.91M | 53.41M | 18.99M | 3.85M | 3.96M | 1.39M | 38.00K | 1.57M | 2.21M | 5.89M | 5.61M | 4.60M | 5.98M | 4.21M | 3.22M | 1.94M | 390.62K | 0.00 |
| Cost of Revenue | 68.93M | 57.90M | 33.21M | 28.17M | 15.05M | 17.77M | 18.07M | 17.94M | 31.77M | 18.37M | 6.81M | 1.33M | 1.30M | 563.40K | 40.67K | 1.56M | 2.15M | 5.12M | 4.77M | 4.11M | 2.88M | 1.95M | 1.52M | 808.63K | 0.00 | 0.00 |
| Gross Profit | 176.99M | 163.85M | 106.65M | 74.18M | 39.80M | 43.39M | 41.42M | 43.62M | 74.14M | 35.04M | 12.18M | 2.52M | 2.67M | 827.86K | -2.67K | 2.77K | 58.95K | 768.44K | 844.85K | 492.91K | 3.09M | 2.26M | 1.70M | 1.14M | 390.62K | 0.00 |
| Gross Profit Ratio | 71.97% | 73.89% | 76.25% | 72.48% | 72.56% | 70.94% | 69.62% | 70.86% | 70.00% | 65.61% | 64.15% | 65.46% | 67.31% | 59.50% | -7.03% | 0.18% | 2.66% | 13.04% | 15.06% | 10.72% | 51.72% | 53.63% | 52.86% | 58.43% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 89.23M | 78.21M | 5.49M | 47.37M | 24.10M | 28.96M | 28.86M | 27.88M | 58.96M | 29.80M | 10.81M | 1.75M | 2.08M | 1.48M | 1.53M | 280.31K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 5.47M | 4.16M | 3.63M | 2.38M | 338.37K | 470.61K | 640.09K | 891.55K | 2.06M | 0.00 | 0.00 | 0.00 | 0.00 | -53.92K | 0.00 | -38.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 94.69M | 82.37M | 5.49M | 49.76M | 24.43M | 29.43M | 29.50M | 28.77M | 61.02M | 29.80M | 10.81M | 1.75M | 2.08M | 1.43M | 1.53M | 241.45K | 508.37K | 506.01K | 833.10K | 653.11K | 3.27M | 2.19M | 1.69M | 1.35M | 99.73K | 35.90K |
| Other Expenses | 81.18M | 77.56M | -442.00K | -3.59M | -855.74K | 781.08K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 677.82K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 175.88M | 159.93M | 88.85M | 67.54M | 35.41M | 40.04M | 41.52M | 41.23M | 83.19M | 37.70M | 12.27M | 2.23M | 2.08M | 1.45M | 1.69M | 275.18K | 555.88K | 738.11K | 1.05M | 825.96K | 3.46M | 2.35M | 1.83M | 1.48M | 456.68K | 0.00 |
| Cost & Expenses | 244.80M | 217.82M | 122.06M | 95.72M | 50.47M | 57.81M | 59.59M | 59.17M | 114.96M | 56.07M | 19.08M | 3.57M | 3.37M | 2.01M | 1.73M | 1.84M | 2.71M | 5.86M | 5.81M | 4.93M | 6.34M | 4.31M | 3.34M | 2.29M | 456.68K | 0.00 |
| Interest Income | 787.00K | -1.75M | -989.00K | 0.00 | 1.84M | 25.68K | 1.55K | 1.40M | 281.42K | 1.50M | 326.91K | 206.77K | -0.43 | 0.00 | 0.00 | 5.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 13.14M | 6.61M | 2.08M | 1.85M | 0.00 | 1.92M | 1.48M | 0.00 | 1.13M | 0.00 | 0.00 | 0.00 | 127.01K | 0.00 | 0.00 | 41.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 0.00 | 40.16M | 29.44M | 22.49M | 14.69M | 13.97M | 15.10M | 15.45M | 13.92M | 8.67M | 2.21M | 374.21K | 297.84K | 116.82K | 7.42K | 33.73K | 47.51K | 236.50K | 217.27K | 177.09K | 186.96K | 166.92K | 135.54K | 130.89K | 77.87K | 262.52 |
| EBITDA | 1.12M | 44.07M | 28.05M | 13.21M | 14.35M | 9.40M | 8.68M | -9.86M | -31.88M | -9.74M | 1.12M | -1.95M | -121.60K | -1.52M | -1.68M | 134.65K | -449.43K | 266.82K | 15.94K | -155.97K | -173.18K | 72.57K | 13.81K | -213.13K | 11.81K | 262.52 |
| EBITDA Ratio | 0.45% | 19.87% | 28.88% | 20.22% | 26.16% | 21.88% | 20.02% | 24.09% | 11.81% | 11.34% | 11.13% | 17.18% | 22.36% | 29.53% | -4,430.78% | 8.60% | -20.32% | 4.53% | 0.28% | -3.39% | -2.99% | 1.72% | 0.43% | -10.96% | 3.02% | 0.00% |
| Operating Income | 1.12M | 3.92M | 4.73M | -1.46M | 3.37M | 2.83M | -110.68K | -12.89M | -40.61M | 7.21M | 2.69M | 296.87K | -548.40K | 294.03K | -1.69M | -816.82K | -496.93K | 30.32K | -201.33K | -333.06K | -365.49K | -94.35K | -121.74K | -344.02K | -66.06K | 0.00 |
| Operating Income Ratio | 0.45% | 1.77% | 3.38% | -1.43% | 6.15% | 4.63% | -0.19% | -20.94% | -38.34% | 13.50% | 14.18% | 7.70% | -13.84% | 21.13% | -4,450.31% | -52.18% | -22.47% | 0.51% | -3.59% | -7.24% | -6.12% | -2.24% | -3.78% | -17.69% | -16.91% | 0.00% |
| Total Other Income/Expenses | -7.77M | -6.62M | -1.80M | -7.87M | -2.19M | -9.53M | -1.13M | -8.59M | -19.24M | -24.57M | -1.58M | -2.77M | 28.45 | -880.89K | 96.13K | 812.89K | -998.42K | -78.71K | 66.08K | -51.73K | -175.87K | -43.47K | 4.12K | 42.21K | 18.15K | 3.82K |
| Income Before Tax | -6.65M | -2.70M | 2.21M | -9.33M | -3.04M | -6.70M | -5.29M | -21.49M | -65.52M | -17.36M | -1.50M | -2.47M | -548.40K | -1.53M | -1.59M | -3.93K | -1.50M | -48.39K | -135.25K | -384.79K | -1.24M | -137.82K | -117.62K | -301.81K | -47.91K | 0.00 |
| Income Before Tax Ratio | -2.71% | -1.22% | 1.58% | -9.11% | -5.55% | -10.96% | -8.90% | -34.90% | -61.86% | -32.51% | -7.90% | -64.05% | -13.84% | -110.14% | -4,197.33% | -0.25% | -67.60% | -0.82% | -2.41% | -8.37% | -20.70% | -3.27% | -3.65% | -15.52% | -12.26% | 0.00% |
| Income Tax Expense | 109.00K | 85.00K | -1.90M | -3.16M | 96.52K | 203.20K | 100.62K | 354.69K | -8.15M | 961.69K | -97.65K | 200.44K | 127.01K | 913.21K | -0.97 | -857.60K | 56.10K | -204.98K | 156.61K | 86.28K | 18.00K | -96.28K | 38.75K | 34.66K | 193.36K | 37.88K |
| Net Income | -6.76M | -2.78M | 4.84M | -6.17M | -3.79M | -5.58M | 14.51M | -19.15M | -57.37M | -18.32M | -1.40M | -2.47M | -548.40K | -1.53M | -1.59M | 1.26M | -1.79M | 715.84K | -291.86K | -710.13K | -1.25M | -41.54K | -156.37K | -336.47K | -241.26K | -34.05K |
| Net Income Ratio | -2.75% | -1.26% | 3.46% | -6.03% | -6.91% | -9.12% | 24.39% | -31.11% | -54.17% | -34.31% | -7.38% | -64.05% | -13.84% | -110.14% | -4,197.33% | 80.68% | -81.04% | 12.15% | -5.20% | -15.44% | -21.00% | -0.99% | -4.85% | -17.30% | -61.76% | 0.00% |
| EPS | -0.16 | -0.07 | 0.14 | -0.20 | -0.17 | -0.27 | 0.72 | -1.02 | -3.23 | -1.60 | -0.22 | -0.72 | -0.17 | -0.51 | -0.74 | 23.08 | -55.02 | 37.58 | -15.98 | -8.88 | -18.94 | -3.57 | -19.78 | -66.08 | -60.76 | -13.57 |
| EPS Diluted | -0.16 | -0.07 | 0.13 | -0.20 | -0.17 | -0.27 | 0.72 | -1.02 | -3.23 | -1.60 | -0.22 | -0.72 | -0.17 | -0.51 | -0.74 | 23.08 | -55.02 | 11.27 | -15.98 | -8.88 | -18.94 | -3.57 | -19.78 | -66.08 | -60.76 | -13.57 |
| Weighted Avg Shares Out | 42.50M | 38.61M | 34.56M | 30.44M | 22.72M | 20.72M | 20.19M | 18.85M | 17.76M | 11.49M | 6.47M | 3.43M | 3.21M | 3.01M | 2.15M | 54.71K | 32.58K | 18.63K | 18.26K | 79.96K | 66.23K | 11.62K | 7.91K | 5.09K | 3.97K | 2.51K |
| Weighted Avg Shares Out (Dil) | 42.50M | 38.61M | 36.30M | 30.44M | 22.72M | 20.72M | 20.19M | 18.85M | 17.76M | 11.49M | 6.47M | 3.43M | 3.21M | 3.01M | 2.15M | 54.71K | 32.58K | 63.47K | 18.26K | 79.96K | 66.23K | 11.62K | 7.91K | 5.09K | 3.97K | 2.51K |
Quipt Home Medical Corp. to Announce Fiscal Fourth Quarter and Full Year 2024 Financial Results on December 16, 2024
CINCINNATI, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal fourth quarter and full year 2024 financial...
Quipt Home Medical: Deep Value With Explosive Upside
Value investing principles from Benjamin Graham emphasize buying undervalued stocks based on arithmetic, not optimism, especially in a record high market. Quipt is significantly undervalued with a $256 million revenue run rate and a $122 million market cap. The aging...
Quipt Home Medical Corp. (QIPT) Q3 2024 Earnings Call Transcript
Quipt Home Medical Corp. (NASDAQ:QIPT ) Q3 2024 Results Conference Call August 15, 2024 10:00 AM ET Company Participants Greg Crawford - Chairman, CEO Hardik Mehta - CFO Conference Call Participants Richard Close - Canaccord Genuity Justin Keywood - Stifel...
Quipt Home Medical Corp. (QIPT) Reports Q3 Loss, Lags Revenue Estimates
Quipt Home Medical Corp. (QIPT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of $0.01. This compares to loss of $0.03 per share a year ago.
Quipt Home Medical Reports Third Quarter Fiscal 2024 Financial Results
CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care, today announced its third quarter fiscal 2024 financial results and operational highlights....
Quipt Home Medical Corp. (QIPT) Reports Next Week: Wall Street Expects Earnings Growth
Quipt Home Medical (QIPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2024 Financial Results on August 14, 2024
CINCINNATI, July 31, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal third quarter 2024 financial results on Wednesday,...
Quipt Home Medical Corp. (QIPT) Q2 2024 Earnings Call Transcript
Quipt Home Medical Corp. (NASDAQ:QIPT ) Q2 2024 Earnings Conference Call May 16, 2024 10:00 AM ET Company Participants Greg Crawford - Chairman, CEO Hardik Mehta - CFO Conference Call Participants Richard Close - Canaccord Genuity Douglas Cooper - Beacon...
Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14%
• Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid (“NCIB”) Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a...
Quipt Home Medical Corp. Announces Filing of Final Base Shelf Prospectus
CINCINNATI, Ohio, May 09, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, has filed and obtained a receipt for its final short...
Source: https://incomestatements.info
Category: Stock Reports